Tag: Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Share

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Revenue Growth On Track For A 14.5% CAGR Through 2030

The real-time blood glucose continuous glucose monitoring (cgm) patch market has experienced rapid expansion in recent years. Its size is projected to increase from $7.04 billion in 2025 to $8.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The historical growth of this market can be attributed to the rising incidence of diabetes, enhanced awareness of glucose self-monitoring, increased adoption of wearable medical devices, the expansion of hospital-based diabetes management, and improvements in sensor accuracy.

The real-time blood glucose continuous glucose monitoring (cgm) patch market is projected to experience substantial expansion over the upcoming years. Its size is anticipated to reach $13.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. This projected growth during the forecast period is attributable to several factors, including the integration of real-time data analytics, the increasing uptake of telehealth, a growing demand for personalized diabetes management solutions, the expansion of homecare diagnostics, and rising investments in continuous monitoring technologies. Key trends observed during this period encompass the increasing adoption of patch-based glucose monitoring systems, a heightened demand for real-time glucose visibility, a noticeable shift towards non-invasive and minimally invasive monitoring methods, the expansion of home-based diabetes management strategies, and a greater utilization of continuous monitoring for early diagnosis.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=84456155&type=smp&name=Real-Time%20Blood%20Glucose%20Continuous%20Glucose%20Monitoring%20%28CGM%29%20Patch%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of diabetes is anticipated to drive the expansion of the real-time blood glucose continuous glucose monitoring (CGM) patch market in the future. Diabetes is defined as a chronic metabolic condition characterized by elevated blood glucose levels, resulting from either insufficient insulin production or insulin resistance. The prevalence of diabetes is escalating as growing obesity leads to higher insulin resistance, which in turn disrupts blood sugar regulation and significantly raises the risk of developing type 2 diabetes. The real-time blood glucose continuous glucose monitoring (CGM) patch enables individuals with diabetes to continuously monitor their blood glucose levels in real time, offering timely alerts for hyperglycemia or hypoglycemia. This empowers them to make informed adjustments to their diet, medication, and lifestyle, ultimately enhancing overall disease management and reducing the potential for complications. For example, in June 2024, according to the National Health Service, a UK-based government department, 2023 saw the NHS identify over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330. This figure signifies a notable rise compared to 3,065,825 in 2022, reflecting an increase of nearly 20%. Consequently, the rising prevalence of diabetes is propelling the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market.

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Segmentation And Category Overview

The real-time blood glucose continuous glucose monitoring (cgm) patch market covered in this report is segmented –

1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch

2) By Technology: Enzymatic, Non-Enzymatic

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications

5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users

Subsegments:

1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch

2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Trends Powering Strategic Industry Growth

Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are prioritizing the development of innovative products, such as over-the-counter continuous glucose monitoring sensors, to broaden access and enhance user convenience. These over-the-counter continuous glucose monitoring (CGM) sensors are wearable devices that meticulously track glucose levels in real time and are available for purchase without a prescription, thereby empowering users to continuously monitor their glucose, comprehend the influence of lifestyle factors on their levels, and more easily manage or prevent diabetes. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, introduced Stelo, its inaugural over-the-counter (OTC) continuous glucose monitoring (CGM) patch in the United States. This compact, wearable sensor is affixed to the back of the upper arm, supplying real-time glucose readings directly to a smartphone application without requiring fingersticks. Specifically designed for individuals with Type 2 diabetes who do not use insulin and those with prediabetes, Stelo provides personalized insights into how diet, exercise, and sleep impact glucose levels. The device offers up to 15-day wear time, is waterproof, features spike and pattern detection, and integrates with Dexcom’s established glucose sensing technology, thereby rendering continuous glucose monitoring more accessible, convenient, and actionable for a wider population.

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Key Participants And Competitive Landscape

Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG

View The Full Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Report:

https://thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market By 2030?

The real-time blood glucose continuous glucose monitoring (cgm) patch market has experienced substantial expansion recently. Projections indicate its size will increase from $7.04 billion in 2025 to $8.08 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Historically, this growth has been driven by factors such as a rise in diabetes prevalence, increased awareness regarding glucose self-monitoring, wider adoption of wearable medical devices, the expansion of hospital-based diabetes management, and advancements in sensor accuracy.

The real-time blood glucose continuous glucose monitoring (cgm) patch market is poised for substantial expansion in the upcoming years. It is projected to attain a size of $13.89 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.5%. The projected increase in this period stems from various factors, including the incorporation of real-time data analytics, the rising adoption of telehealth, the demand for individualized diabetes management, the expansion of homecare diagnostic services, and increased investment in continuous monitoring technologies. Significant trends anticipated during the forecast period encompass a greater acceptance of patch-based glucose monitoring, an escalating need for immediate glucose visibility, a pivot towards non-invasive and minimally invasive monitoring methods, the broadening of home-based diabetes management strategies, and an enhanced utilization of continuous monitoring for early diagnosis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29166&type=smp

What Primary Factors Are Fueling The Expansion Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The increasing prevalence of diabetes is anticipated to propel the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market in the future. Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels, resulting from either insufficient insulin production or insulin resistance. The rise in diabetes prevalence is linked to increasing obesity, which leads to higher insulin resistance, thereby disrupting blood sugar regulation and significantly elevating the risk of developing type 2 diabetes. A real-time blood glucose continuous glucose monitoring (CGM) patch enables individuals with diabetes to consistently monitor their blood glucose levels in real time, offering timely alerts for hyperglycemia or hypoglycemia. This capability supports them in making informed dietary, medication, and lifestyle adjustments, ultimately enhancing overall disease management and reducing the likelihood of complications. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the NHS identified over 549,000 additional individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, representing a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the growing prevalence of diabetes is driving the expansion of the real-time blood glucose continuous glucose monitoring (CGM) patch market.

What Are The Core Segment Classifications In The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The real-time blood glucose continuous glucose monitoring (cgm) patch market covered in this report is segmented –

1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch

2) By Technology: Enzymatic, Non-Enzymatic

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications

5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users

Subsegments:

1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch

2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch

Which Trends Are Expected To Shape The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are concentrating on creating advanced products, such as over-the-counter continuous glucose monitoring sensors, to broaden accessibility and enhance user ease. Over-the-counter continuous glucose monitoring (CGM) sensors are wearable devices that monitor glucose levels constantly and can be acquired without a prescription, enabling users to track their glucose continuously, comprehend how lifestyle influences their levels, and manage or prevent diabetes more simply. For example, in September 2024, Dexcom Inc., a US-based diabetes technology firm, introduced Stelo, its initial over-the-counter (OTC) continuous glucose monitoring (CGM) patch in the United States. This compact, wearable sensor is applied to the back of the upper arm and transmits real-time glucose data directly to a smartphone application, removing the need for fingersticks. Intended for individuals with Type 2 diabetes not using insulin and those with prediabetes, Stelo offers personalized insights into how diet, exercise, and sleep affect glucose levels. The device boasts up to 15 days of wear time, is waterproof, detects spikes and patterns, and incorporates Dexcom’s established glucose sensing technology, thereby making continuous glucose monitoring more attainable, practical, and effective for a larger demographic.

Who Are The Leading Firms Participating In The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG

Access The Complete Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Report:

https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report

Which Region Stands As The Largest Contributor To The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report

Browse Through More Reports Similar to the Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market 2026, By The Business Research Company

Continuous Glucose Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Blood Glucose Monitoring Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Blood Glucose Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Across 2026–2030?

The real-time blood glucose continuous glucose monitoring (cgm) patch market size has expanded rapidly in recent years. Projections indicate it will grow from $7.04 billion in 2025 to $8.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. The historical growth in this sector is attributable to factors such as increasing diabetes prevalence, rising awareness of glucose self-monitoring, growing adoption of wearable medical devices, expanding hospital-based diabetes management, and improving sensor accuracy.

The market for real-time blood glucose continuous glucose monitoring (CGM) patches is anticipated to experience substantial growth over the coming years. Projections indicate this market will reach $13.89 billion by 2030, expanding at a compound annual growth rate (CAGR) of 14.5%. This expansion during the forecast period is fueled by several factors, including the incorporation of real-time data analytics, greater adoption of telehealth services, a demand for tailored diabetes management solutions, the broadening of homecare diagnostics, and increased investment in continuous monitoring technologies. Key developments anticipated in the forecast period encompass a surge in the acceptance of patch-based glucose monitoring, a heightened need for immediate glucose insights, a movement towards less invasive and non-invasive monitoring methods, the growth of home-based diabetes care, and the expanded application of continuous monitoring in early detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29166&type=smp

What Primary Drivers Are Shaping The Development Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The real-time blood glucose continuous glucose monitoring (CGM) patch market is projected to expand due to the escalating prevalence of diabetes. Diabetes is defined as a chronic metabolic condition characterized by elevated blood glucose levels, resulting from either insufficient insulin production or insulin resistance. The rise in diabetes cases is attributed to increasing obesity, which leads to heightened insulin resistance, thereby disrupting blood sugar regulation and significantly increasing the likelihood of developing type 2 diabetes. The real-time blood glucose continuous glucose monitoring (CGM) patch enables individuals with diabetes to continuously track their blood glucose levels in real time, delivering timely alerts for both hyperglycemia and hypoglycemia. This functionality assists them in making informed decisions about diet, medication, and lifestyle, ultimately enhancing overall disease management and lowering the risk of complications. As an illustration, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the NHS identified over half a million (549,000) additional people in England at risk of developing type 2 diabetes. This brought the total number of individuals with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330. This figure represents a notable increase compared to 3,065,825 in 2022, signifying a growth of nearly 20%. Hence, the growing prevalence of diabetes is a key factor driving the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market.

What Segmentation Levels Are Considered In The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The real-time blood glucose continuous glucose monitoring (cgm) patch market covered in this report is segmented –

1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch

2) By Technology: Enzymatic, Non-Enzymatic

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications

5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users

Subsegments:

1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch

2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch

What Trends Are Projected To Affect The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

Leading companies within the real-time blood glucose continuous glucose monitoring (CGM) patch market are concentrating on developing novel products, such as over-the-counter continuous glucose monitoring sensors, to broaden availability and enhance user ease. These over-the-counter continuous glucose monitoring (CGM) sensors are wearable devices that continuously track glucose levels and can be acquired without a prescription, enabling individuals to monitor their glucose constantly, comprehend how lifestyle factors influence their levels, and simplify the management or prevention of diabetes. For example, in September 2024, Dexcom Inc., a US-based diabetes technology firm, introduced Stelo, its initial over-the-counter (OTC) continuous glucose monitoring (CGM) patch, in the United States. This compact, wearable sensor is placed on the back of the upper arm and transmits real-time glucose readings directly to a smartphone application, eliminating the requirement for fingersticks. Designed for individuals with Type 2 diabetes who do not use insulin and those with prediabetes, Stelo offers customized insights into how diet, exercise, and sleep impact glucose levels. The device boasts up to a 15-day wear time, waterproof capabilities, detection of spikes and patterns, and incorporates Dexcom’s established glucose sensing technology, thereby making continuous glucose monitoring more attainable, convenient, and practical for a wider demographic.

Which Leading Firms Are Contributing To The Growth Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG

Read the full real-time blood glucose continuous glucose monitoring (cgm) patch market report here:

https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report

How Does The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Perform Across Major Global Regions?

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29166&type=smp

Browse Through More Reports Similar to the Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market 2026, By The Business Research Company

Continuous Glucose Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Blood Glucose Monitoring Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Blood Glucose Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market show for the 2026–2030 period?

The real-time blood glucose continuous glucose monitoring (cgm) patch market has experienced rapid growth recently. It is forecast to increase from $7.04 billion in 2025 to $8.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. This historical growth can be linked to factors such as the rising incidence of diabetes, heightened awareness of glucose self-monitoring, increased acceptance of wearable medical devices, expanding hospital-based diabetes management programs, and enhancements in sensor accuracy.

The real-time blood glucose continuous glucose monitoring (cgm) patch market is anticipated to undergo significant expansion in the coming years. It is projected to achieve a size of $13.89 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.5%. This expansion during the forecast period is primarily driven by the integration of real-time data analytics, the growing adoption of telehealth services, the increasing demand for personalized diabetes management, the broadening scope of homecare diagnostics, and an uptick in investment within continuous monitoring technologies. Prominent trends expected in this period include the increasing uptake of patch-based glucose monitoring, the rising need for immediate glucose visibility, a shift towards non-invasive and minimally invasive monitoring solutions, the growth of home-based diabetes management strategies, and an increased application of continuous monitoring in early disease diagnosis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29166&type=smp

What Drivers Are Shaping The Development Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The increasing incidence of diabetes is projected to fuel the expansion of the real-time blood glucose continuous glucose monitoring (CGM) patch market in the future. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or resistance to insulin. The prevalence of diabetes is escalating as growing obesity leads to higher insulin resistance, which disrupts blood sugar regulation and significantly raises the risk of developing type 2 diabetes. The real-time blood glucose continuous glucose monitoring (CGM) patch allows individuals with diabetes to continuously track their blood glucose levels in real time, providing prompt alerts for hyperglycemia or hypoglycemia. This capability helps them make informed dietary, medication, and lifestyle modifications, ultimately enhancing overall disease management and reducing the likelihood of complications. For instance, in June 2024, the National Health Service, a UK-based government department, reported that in 2023, the NHS identified an additional 549,000 individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This figure represents a notable increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Consequently, the rising prevalence of diabetes is a key driver for the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market.

Which Segments Are Contributing To The Growth Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The real-time blood glucose continuous glucose monitoring (cgm) patch market covered in this report is segmented –

1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch

2) By Technology: Enzymatic, Non-Enzymatic

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications

5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users

Subsegments:

1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch

2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch

Which Innovation Trends Are Advancing Developments Within The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

Companies operating within the real-time blood glucose continuous glucose monitoring (CGM) patch market are primarily concentrating on creating novel products, such as over-the-counter continuous glucose monitoring sensors, to widen access and improve ease of use for consumers. These over-the-counter (CGM) sensors are wearable devices that continuously track glucose levels and can be acquired without a prescription, enabling users to monitor their glucose constantly, understand the influence of lifestyle factors on their levels, and more readily manage or prevent diabetes. As an illustration, in September 2024, Dexcom Inc., a US-based diabetes technology firm, introduced Stelo, its inaugural over-the-counter (OTC) continuous glucose monitoring (CGM) patch in the United States. This compact, wearable sensor is applied to the back of the upper arm and transmits real-time glucose readings directly to a smartphone application, eliminating the need for fingersticks. Designed for individuals with Type 2 diabetes who do not use insulin, as well as those with prediabetes, Stelo offers customized insights into how diet, exercise, and sleep affect glucose levels. The device boasts features such as up to 15-day wear time, waterproofing, detection of spikes and patterns, and incorporates Dexcom’s established glucose sensing technology, thereby making continuous glucose monitoring more attainable, convenient, and practical for a broader segment of the population.

Who Are The Core Companies Influencing Trends In The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29166&type=smp

Browse Through More Reports Similar to the Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market 2026, By The Business Research Company

Continuous Glucose Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Blood Glucose Monitoring Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Blood Glucose Meters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company